Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

745
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
745
Development of Immunocompetence01:22

Development of Immunocompetence

283
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
283
Special Features of Adaptive Immunity01:20

Special Features of Adaptive Immunity

745
The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
745
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

452
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
452
Humoral Immune Responses01:36

Humoral Immune Responses

71.4K
Overview
71.4K
Viral Mutations00:36

Viral Mutations

32.1K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.1K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Antagonism of stress granules key for SARS-CoV-2 infection and pathogenesis.

bioRxiv : the preprint server for biology·2026
Same author

Intranasal boosting induces variant-specific responses in SARS-CoV-2 vaccine-imprinted mice.

Nature communications·2026
Same author

Antigenic characterization of SARS-CoV-2 variants BA.3.2.1 and BA.3.2.2 in three animal models.

bioRxiv : the preprint server for biology·2026
Same author

Immunological imprinting shapes the cross-reactive antibody responses to the KP.2 and LP.8.1 vaccine doses.

bioRxiv : the preprint server for biology·2026
Same author

TMPRSS2-mediated coronavirus spike activation and inhibition.

Nature structural & molecular biology·2026
Same author

Increased CSF volume, altered brain development and emotional reactivity after postnatal Zika virus infection in infant rhesus macaques.

bioRxiv : the preprint server for biology·2026
Same journal

The Neuroimmune Circuitry of Peripheral Sensory Neuron Subtypes in Chronic Pain.

Annual review of immunology·2026
Same journal

The Spectrum of Fibroblast Immune Biology.

Annual review of immunology·2026
Same journal

The Molecular Logic of Immunoglobulin Heavy Chain Class Switch Recombination.

Annual review of immunology·2026
Same journal

Decoding Human T Cell Immunity with Artificial Intelligence and Single-Cell Genomics.

Annual review of immunology·2026
Same journal

Immune Niches in Cancer.

Annual review of immunology·2026
Same journal

T Cell Receptor Signaling and Immune Tolerance: From Autoimmunity to Cancer Immunity.

Annual review of immunology·2026
查看所有相关文章

相关实验视频

Updated: Jun 4, 2025

Visualization of SARS-CoV-2 using Immuno RNA-Fluorescence In Situ Hybridization
05:23

Visualization of SARS-CoV-2 using Immuno RNA-Fluorescence In Situ Hybridization

Published on: December 23, 2020

6.0K

SARS-CoV-2:进化与宿主免疫之间的相互作用

James Brett Case1, Shilpi Jain2,3, Mehul S Suthar2,3

  • 1Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA;

Annual review of immunology
|December 20, 2024
PubMed
概括
此摘要是机器生成的。

SARS-CoV-2 病毒通过突变进化,导致新的变种挑战疫苗的有效性. 持续的病毒进化,由免疫逃生驱动,需要新的策略来控制传播.

关键词:
这就是SARS-CoV-2病毒.进化 演化 演化 演化 演化 演化 演化 演化免疫力是一种免疫力.保护 保护 保护 保护疫苗,疫苗的使用情况.变种变种的变种

更多相关视频

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
06:03

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays

Published on: September 20, 2024

1.2K
Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection
10:25

Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection

Published on: June 5, 2021

4.6K

相关实验视频

Last Updated: Jun 4, 2025

Visualization of SARS-CoV-2 using Immuno RNA-Fluorescence In Situ Hybridization
05:23

Visualization of SARS-CoV-2 using Immuno RNA-Fluorescence In Situ Hybridization

Published on: December 23, 2020

6.0K
Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
06:03

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays

Published on: September 20, 2024

1.2K
Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection
10:25

Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection

Published on: June 5, 2021

4.6K

科学领域:

  • 病毒学 病毒学
  • 免疫学 免疫学 免疫学
  • 流行病学 流行病学

背景情况:

  • 全球 SARS-CoV-2 的持续性是由具有独特突变的新变种菌株的出现所驱动的.
  • 病毒进化受到宿主免疫力,疾病对策和加强传播的选择的影响.
  • 病毒的多样性给疫苗的有效性带来了挑战,特别是幽默免疫力.

研究的目的:

  • 审查大流行期间SARS-CoV-2的演变.
  • 了解提供对SARS-CoV-2的保护的免疫机制.
  • 评估病毒演变对传播能力和适应性免疫力的影响.

主要方法:

  • 审查有关SARS-CoV-2演变的现有科学文献.
  • 对自然感染和疫苗接种的免疫反应的分析.
  • 检查影响病毒传播能力和免疫逃脱的因素.

主要成果:

  • 起初,SARS-CoV-2的演变有利于增加传播能力.
  • 目前的病毒进化主要是由免疫逃生机制驱动的.
  • 病毒的多样性会影响现有疫苗的有效性和自然免疫力.

结论:

  • SARS-CoV-2 可能会继续演变以保持健康.
  • 需要有效的对策来破坏病毒传播周期.
  • 了解病毒进化对于开发下一代疫苗和疗法至关重要.